Taylor Roger John
Novartis
6 Papers
65 Citations
Taylor Roger John is an academic researcher from Novartis. The author has contributed to research in topics: Adenosine A2A receptor & Adenosine. The author has an hindex of 4, co-authored 6 publications.
Chat about Author
Papers
Patent
Adenosine derivatives as a2a receptor agonists
Fairhurst Robin Alec,Taylor Roger John +1 more
- 13 Sep 2007
TL;DR: In this paper, the A2A receptor activation of the adenosine A 2A receptor has been studied and a process for preparing the compounds is described, as well as pharmaceutical compositions that contain the compounds.
35
Patent
Purine derivatives acting as a2a receptor agonists
Fairhurst Robin Alec,Taylor Roger John +1 more
- 12 Jan 2006
TL;DR: In this article, the adenosine A2A receptor (A2A) mediated conditions mediated by activation of the A 2A receptor, especially inflammatory or obstructive airway diseases, are described.
13
Patent
Adenosine derivatives having a2a receptor activity
Fairhurst Robin Alec,Taylor Roger John +1 more
- 13 Mar 2006
TL;DR: In this paper, the adenosine A2A receptor was used to treat conditions mediated by activation of the A 2A receptor, especially inflammatory or obstructive airway diseases.
9
Patent
Purine derivatives as a2a agonists
Fairhurst Robin Alec,Taylor Roger John +1 more
- 11 Jul 2007
TL;DR: In this paper, the adenosine A2A receptor was used to treat conditions mediated by activation of the A 2A receptor, especially inflammatory or obstructive airway diseases.
6
Patent
Bisadenosine compounds as adenosine a2a receptor agonists
Fairhurst Robin Alec,Taylor Roger John +1 more
- 19 Apr 2007
TL;DR: A compound of formula (I), or stereoisomers or pharmaceutically acceptable salts thereof, wherein, R 1a, 1b, R 2a, R2b, U 1, U2, X 1, X2 and L are as defined herein this paper.
1